tiprankstipranks
Cardiol Therapeutics (TSE:CRDL)
TSX:CRDL
Canadian Market
CRDL
Cardiol Therapeutics
RESEARCH TOOLSreports
Want to see TSE:CRDL full AI Analyst Report?

Cardiol Therapeutics (CRDL) Financial Statements

222 Followers

Cardiol Therapeutics Financial Overview

Cardiol Therapeutics's market cap is currently C$200.25M. The company's EPS TTM is C$-0.3912; its P/E ratio is -4.76; Cardiol Therapeutics is scheduled to report earnings on May 11, 2026, and the estimated EPS forecast is C$-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Dec 22Dec 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 78.76K
Gross ProfitC$ 0.00C$ -373.11KC$ -248.35KC$ -219.91KC$ 78.76K
Operating IncomeC$ -34.32MC$ -40.28MC$ -29.79MC$ -50.34MC$ -45.47M
EBITDAC$ -34.21MC$ -36.30MC$ -27.88MC$ -30.71MC$ -38.44M
Net IncomeC$ -33.82MC$ -36.68MC$ -28.13MC$ -11.52MC$ -24.72M
Balance Sheet
Cash & Short-Term InvestmentsC$ 21.42MC$ 30.58MC$ 34.93MC$ 59.47MC$ 83.90M
Total AssetsC$ 23.62MC$ 31.86MC$ 36.70MC$ 62.03MC$ 87.88M
Total DebtC$ 125.52KC$ 158.53KC$ 158.53KC$ 72.87KC$ 117.58K
Net DebtC$ -21.29MC$ -30.42MC$ -34.77MC$ -59.40MC$ -83.78M
Total LiabilitiesC$ 5.74MC$ 7.14MC$ 8.45MC$ 9.83MC$ 11.64M
Stockholders' EquityC$ 17.88MC$ 24.73MC$ 28.25MC$ 52.20MC$ 76.24M
Cash Flow
Free Cash FlowC$ -23.88MC$ -25.08MC$ -25.25KC$ -27.30MC$ -23.56M
Operating Cash FlowC$ -23.85MC$ -25.06MC$ -25.18KC$ -27.22MC$ -23.55M
Investing Cash FlowC$ -24.48KC$ -21.29KC$ -64.31KC$ -74.71KC$ -12.92K
Financing Cash FlowC$ 15.54MC$ 18.84MC$ -55.38KC$ -53.93KC$ 93.44M
Currency in CAD

Cardiol Therapeutics Earnings and Revenue History

Income Statement >

Cardiol Therapeutics Debt to Assets

Balance Sheet >

Cardiol Therapeutics Cash Flow

Cash Flow >

Cardiol Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >